Service Standard for Registration of an Establishment under the Safety of Human Cells, Tissues and Organs for Transplantation Regulations
Disclaimer: Information on this webpage is provided for illustrative purposes only. The Safety of Human Cells, Tissues and Organs for Transplantation Regulations (CTO Regulations or Regulations) should be relied upon for specific requirements, including if there are discrepancies between this page and the CTO Regulations.
Health Canada posts service standards and performance information for services with over 100 regulatory authorizations, such as permits, licences, or registrations issued each year (high-volume regulatory transactions).
The Safety of Human Cells, Tissues and Organs for Transplantation Regulations (CTO Regulations or Regulations) contain safety requirements with respect to processing; storage; record keeping; distribution; importation; and conducting investigations and reporting of errors, accidents, and adverse reactions. Processing includes donor screening; donor testing; donor suitability assessment; retrieval (except in the case of organs and islet cells); testing and measurements performed on the cells, tissues or organs (CTO) after they are retrieved; preparation for use in transplantation (except for organs); preservation; quarantine; banking; packaging; and labelling. These Regulations are intended to result in improved protection of the health and safety of Canadian transplant recipients.
The Guidance Document for Cell, Tissue and Organ Establishments - Safety of Human Cells, Tissues and Organs for Transplantation is intended to provide an interpretation of the CTO Regulations. Both the scope of the CTO Regulations, as well as the activities they govern are outlined. It is intended to be an important point of reference. It helps readers determine whether a product and the related activities are governed by the CTO Regulations, and gives more detail as to which requirements must be fulfilled. The requirements that are discussed in this document are the current safety requirements for CTO used in transplantation.
The Regulatory Operations and Enforcement Branch (ROEB) commits to a service delivery standard of 90 calendar days for the issuance of a decision on an application for registration of a cell, tissue and organ (CTO) establishment, including the review of initial and renewal registration applications, from the date of receipt of a complete application.
The target for achieving this standard is set at 90% of submissions being completed within applicable review timelines.
Performance result in fiscal year 2020 to 2021:
Annual service performance is measured over the course of the fiscal year (April 1 - March 31).
In 2020-2021, ROEB completed 99% of submissions within applicable review timelines.
All completed applications, as well as all inquiries pertaining to the status of an establishment's registration should be sent to the Biological Product Compliance Program at the following email address: firstname.lastname@example.org
Biological Product Compliance Program (BPCP)
200 Eglantine Driveway, Tunney’s Pasture
3rd Floor, Jeanne Mance Building
Address Locator: 1903D
Ottawa, Ontario K1A 0K9
All other inquiries can be directed to the Office of Policy and International Collaboration in the Biologic and Radiopharmaceutical Drugs Directorate at email@example.com.
Report a problem or mistake on this page
- Date modified: